
Two dead in MP GBS outbreak, Doctors say rare nerve disorder not contagious
The death of two people due to Guillain-Barré Syndrome (GBS) in Manasa town of Neemuch district has prompted the Madhya Pradesh government to intensify surveillance, treatment and awareness measures, even as medical experts stress that the rare neurological condition is not contagious and does not pose the risk of spreading across the country like swine flu or COVID-19.
GBS is a rare autoimmune disorder in which the body’s immune system mistakenly attacks the peripheral nervous system. The condition can cause sudden numbness, muscle weakness and, in severe cases, difficulty in swallowing or breathing. Symptoms often begin with tingling or weakness in the legs and may progress upwards, worsening over days or weeks before stabilising.
Doctors explain that GBS is not an infectious disease and cannot be transmitted from person to person. Instead, it usually develops after a prior infection such as a viral illness, bacterial diarrhoea or food poisoning. In some cases, it has been linked to the consumption of undercooked poultry, unpasteurised dairy products or contaminated water. Health experts underline that the infection occurs first, and GBS develops later as an abnormal immune reaction.
Medical professionals have ruled out the possibility of the disease spreading across India, noting that GBS does not spread through air, touch or close contact. When multiple cases are reported in one area, it is typically due to exposure to a common trigger rather than human-to-human transmission.
While the condition can be serious, it is rarely fatal. Globally, the fatality rate is estimated at around 3 to 5 per cent, with deaths usually occurring due to respiratory failure or complications in critical cases. Officials emphasise that early diagnosis and timely intensive care significantly improve survival chances, and most patients eventually recover fully, although recovery can take several weeks or months.
There is no single drug that cures GBS, but effective treatments are available to halt the immune attack on nerves. These include intravenous immunoglobulin therapy and plasmapheresis, a procedure that removes harmful antibodies from the blood. Supportive care such as ventilator support, oxygen therapy, pain management and physiotherapy plays a key role in recovery.
Following the detection of 14 cases in Manasa, the state government has set up a control room, created a dedicated ward for GBS patients at the local government hospital, deployed ambulances equipped with life-saving systems, and launched door-to-door health surveys and public awareness campaigns. The government is bearing the cost of treatment for affected patients. Samples of water, food and blood have been sent to national laboratories to determine the source of the outbreak, which is yet to be ascertained.
Health authorities have advised residents to remain alert but not panic, stressing that GBS is rare, non-contagious and treatable when identified early. People have been urged to seek immediate medical attention if they experience sudden weakness or numbness following an illness and to follow basic food and water safety measures.
